These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 36765853)
21. Towards Unravelling the Role of ERα-Targeting miRNAs in the Exosome-Mediated Transferring of the Hormone Resistance. Andreeva OE; Sorokin DV; Mikhaevich EI; Bure IV; Shchegolev YY; Nemtsova MV; Gudkova MV; Scherbakov AM; Krasil'nikov MA Molecules; 2021 Nov; 26(21):. PubMed ID: 34771077 [TBL] [Abstract][Full Text] [Related]
22. Downregulation of miR-342 is associated with tamoxifen resistant breast tumors. Cittelly DM; Das PM; Spoelstra NS; Edgerton SM; Richer JK; Thor AD; Jones FE Mol Cancer; 2010 Dec; 9():317. PubMed ID: 21172025 [TBL] [Abstract][Full Text] [Related]
23. Exosomal annexin A6 induces gemcitabine resistance by inhibiting ubiquitination and degradation of EGFR in triple-negative breast cancer. Li T; Tao Z; Zhu Y; Liu X; Wang L; Du Y; Cao J; Wang B; Zhang J; Hu X Cell Death Dis; 2021 Jul; 12(7):684. PubMed ID: 34238922 [TBL] [Abstract][Full Text] [Related]
24. Poly-ADP-Ribosylation of Estrogen Receptor-Alpha by PARP1 Mediates Antiestrogen Resistance in Human Breast Cancer Cells. Pulliam N; Tang J; Wang W; Fang F; Sood R; O'Hagan HM; Miller KD; Clarke R; Nephew KP Cancers (Basel); 2019 Jan; 11(1):. PubMed ID: 30621214 [TBL] [Abstract][Full Text] [Related]
25. Addition of a histone deacetylase inhibitor redirects tamoxifen-treated breast cancer cells into apoptosis, which is opposed by the induction of autophagy. Thomas S; Thurn KT; Biçaku E; Marchion DC; Münster PN Breast Cancer Res Treat; 2011 Nov; 130(2):437-47. PubMed ID: 21298336 [TBL] [Abstract][Full Text] [Related]
26. Alveolar macrophage-derived exosomal tRF-22-8BWS7K092 activates Hippo signaling pathway to induce ferroptosis in acute lung injury. Wang W; Zhu L; Li H; Ren W; Zhuo R; Feng C; He Y; Hu Y; Ye C Int Immunopharmacol; 2022 Jun; 107():108690. PubMed ID: 35299002 [TBL] [Abstract][Full Text] [Related]
27. Gly-tRF enhances LCSC-like properties and promotes HCC cells migration by targeting NDFIP2. Zhou Y; Hu J; Liu L; Yan M; Zhang Q; Song X; Lin Y; Zhu D; Wei Y; Fu Z; Hu L; Chen Y; Li X Cancer Cell Int; 2021 Sep; 21(1):502. PubMed ID: 34537070 [TBL] [Abstract][Full Text] [Related]
28. Exosomes from tamoxifen-resistant breast cancer cells transmit drug resistance partly by delivering miR-9-5p. Liu J; Zhu S; Tang W; Huang Q; Mei Y; Yang H Cancer Cell Int; 2021 Jan; 21(1):55. PubMed ID: 33451320 [TBL] [Abstract][Full Text] [Related]
29. LncRNA LINP1 confers tamoxifen resistance and negatively regulated by ER signaling in breast cancer. Ma T; Liang Y; Li Y; Song X; Zhang N; Li X; Chen B; Zhao W; Wang L; Yang Q Cell Signal; 2020 Apr; 68():109536. PubMed ID: 31927036 [TBL] [Abstract][Full Text] [Related]
30. tRF-Leu reverse breast cancer cells chemoresistance by regulation of BIRC5. Sun L; Jiao YW; Cui FQ; Liu J; Xu ZY; Sun DL Discov Oncol; 2024 Sep; 15(1):449. PubMed ID: 39278863 [TBL] [Abstract][Full Text] [Related]
31. Survivin plays as a resistant factor against tamoxifen-induced apoptosis in human breast cancer cells. Moriai R; Tsuji N; Moriai M; Kobayashi D; Watanabe N Breast Cancer Res Treat; 2009 Sep; 117(2):261-71. PubMed ID: 18815881 [TBL] [Abstract][Full Text] [Related]
32. miR-449a Suppresses Tamoxifen Resistance in Human Breast Cancer Cells by Targeting ADAM22. Li J; Lu M; Jin J; Lu X; Xu T; Jin S Cell Physiol Biochem; 2018; 50(1):136-149. PubMed ID: 30278449 [TBL] [Abstract][Full Text] [Related]
33. Tamoxifen enhances the cytotoxic effects of nelfinavir in breast cancer cells. Brüning A; Friese K; Burges A; Mylonas I Breast Cancer Res; 2010; 12(4):R45. PubMed ID: 20594311 [TBL] [Abstract][Full Text] [Related]
34. tRNA-Derived Fragment tRF-17-79MP9PP Attenuates Cell Invasion and Migration Mo D; He F; Zheng J; Chen H; Tang L; Yan F Front Oncol; 2021; 11():656078. PubMed ID: 33912465 [TBL] [Abstract][Full Text] [Related]
35. tRNA Yang C; Lee M; Song G; Lim W Pharmaceutics; 2021 Jan; 13(1):. PubMed ID: 33406670 [TBL] [Abstract][Full Text] [Related]
36. 5'-tRF-GlyGCC promotes breast cancer metastasis by increasing fat mass and obesity-associated protein demethylase activity. Chen F; Song C; Meng F; Zhu Y; Chen X; Fang X; Ma D; Wang Y; Zhang C Int J Biol Macromol; 2023 Jan; 226():397-409. PubMed ID: 36464183 [TBL] [Abstract][Full Text] [Related]
37. Tumor-associated macrophages secrete CC-chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer. Li D; Ji H; Niu X; Yin L; Wang Y; Gu Y; Wang J; Zhou X; Zhang H; Zhang Q Cancer Sci; 2020 Jan; 111(1):47-58. PubMed ID: 31710162 [TBL] [Abstract][Full Text] [Related]
38. Global profile of tRNA-derived small RNAs in gastric cancer patient plasma and identification of tRF-33-P4R8YP9LON4VDP as a new tumor suppressor. Shen Y; Yu X; Ruan Y; Li Z; Xie Y; Yan Z; Guo J Int J Med Sci; 2021; 18(7):1570-1579. PubMed ID: 33746573 [TBL] [Abstract][Full Text] [Related]
39. MiR-214 increases the sensitivity of breast cancer cells to tamoxifen and fulvestrant through inhibition of autophagy. Yu X; Luo A; Liu Y; Wang S; Li Y; Shi W; Liu Z; Qu X Mol Cancer; 2015 Dec; 14():208. PubMed ID: 26666173 [TBL] [Abstract][Full Text] [Related]
40. Plasma tRNA Fragments Derived from 5' Ends as Novel Diagnostic Biomarkers for Early-Stage Breast Cancer. Wang J; Ma G; Li M; Han X; Xu J; Liang M; Mao X; Chen X; Xia T; Liu X; Wang S Mol Ther Nucleic Acids; 2020 Sep; 21():954-964. PubMed ID: 32814252 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]